Vertical Longevity Pharmaceuticals

Biotechnology Research • Irvine, California, United States • 1-10 Employees

Company overview

Headquarters	Irvine, California, United States
Website	vertical-longevity-pharma.com
NAICS	541714
Founded	2024
Employees	1-10

Key Contact at Vertical Longevity Pharmaceuticals

David Scieszka

Founder and CEO

About Vertical Longevity Pharmaceuticals

At VLP, we leverage the virus-like particle platform to target senescent cells. Preclinical data revealed a therapeutic benefit in every organ system investigated, including curative potential for atherosclerosis, the leading cause of mortality in the US. We have our sights set on a global market, with thermostability eliminating the need for cold-chain logistics and allowing our advanced injectable to reach the furthest corners of the globe.

Vertical Longevity Pharmaceuticals revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Vertical Longevity Pharmaceuticals has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Vertical Longevity Pharmaceuticals has never raised funding before.

Frequently asked questions

Vertical Longevity Pharmaceuticals is located in Irvine, California, US.

Vertical Longevity Pharmaceuticals was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Vertical Longevity Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Vertical Longevity Pharmaceuticals

David Scieszka

Founder and CEO

4.8

40,000 users